Jelly Roll candidly shared the reason he was inspired to embark on his 200-lb weight loss journey, admitting that he was worried about how his lifespan could be impacted.
At 500+ pounds, Jelly Roll thought he had just months to live. The country singer shares his urgent weight loss journey on ...
Jenny McCarthy debuted her new slimmed-down figure after she revealed her yearlong medical crisis. The former Playboy model, 53, put her trim figure on display in a red bikini as she posed alongside ...
Novo Nordisk (NYSE:NVO) is one of the most profitable large cap stocks to buy right now. On November 10, Novo Nordisk announced new post hoc analysis data from the ESSENCE Phase 3 trial regarding the ...
An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ...
A new weight loss pill has shown promise as a more convenient medication for adults with obesity and type 2 diabetes. The once-daily pill appears to be effective and safe for these patients, according ...
In March, Trainor went public with her decision to take Mounjaro for weight loss Madison E. Goldberg received her B.S. in Journalism and double minors in publishing and photography from Emerson ...
Meghan Trainor turned heads at a Los Angeles Gala with her unrecognizable look following her massive 60-pound weight loss and plastic surgery, RadarOnline.com can reveal. The All About That Bass ...
Meghan Trainor turned heads, and nearly broke the internet, when she showed off her stunning weight loss transformation at the 2025 Baby2Baby Gala in Los Angeles. The 31-year-old singer looked nearly ...
On Thursday, Eli Lilly and Co. (NYSE:LLY) released data from a Phase 2 trial evaluating the safety and efficacy of eloralintide, an investigational once-weekly, selective amylin receptor agonist, in ...
Eli Lilly said on Thursday it will start late-stage trials of its experimental obesity drug next month after it helped patients lose as much as 20.1% of their weight in a mid-stage trial. The ...